Biologists unravel drug-resistance mechanism in tumor cells
from Massachusetts Institute of Technology via ScienceDaily
Cancer biologists have discovered that targeting the RNA-binding protein that promotes drug-resistance could lead to better cancer therapies. About half of all tumors are missing a gene called p53, which helps healthy cells prevent genetic mutations.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063